Healthcare provider profile · identity verified

Jorge Ramirez, D.O.

Family Practice · PORTLAND, TX · NPI 1235407214

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	324	107
Levothyroxine Sodium	Levothyroxine Sodium	272	82
Lisinopril	Lisinopril	253	79
Amlodipine Besylate	Amlodipine Besylate	210	72
Metformin Hcl	Metformin Hcl	181	63
Gabapentin	Gabapentin	176	62
Losartan Potassium	Losartan Potassium	175	53
Tramadol Hcl	Tramadol Hcl	172	40
Furosemide	Furosemide	169	51
Rosuvastatin Calcium	Rosuvastatin Calcium	153	51
Acetaminophen-Codeine	Acetaminophen With Codeine	149	43
Albuterol Sulfate Hfa	Albuterol Sulfate	136	59
Famotidine	Famotidine	134	55
Metoprolol Succinate	Metoprolol Succinate	124	46
Ozempic	Semaglutide	117	24
Pantoprazole Sodium	Pantoprazole Sodium	115	38
Hydrochlorothiazide	Hydrochlorothiazide	112	39
Alendronate Sodium	Alendronate Sodium	109	38
Montelukast Sodium	Montelukast Sodium	107	38
Escitalopram Oxalate	Escitalopram Oxalate	101	34
Fluticasone Propionate	Fluticasone Propionate	100	38
Omeprazole	Omeprazole	92	30
Tamsulosin Hcl	Tamsulosin Hcl	85	31
Tizanidine Hcl	Tizanidine Hcl	85	32
Metoprolol Tartrate	Metoprolol Tartrate	78	23
Trazodone Hcl	Trazodone Hcl	78	20
Potassium Chloride	Potassium Chloride	77	22
Azithromycin	Azithromycin	70	55
Hydroxyzine Hcl	Hydroxyzine Hcl	65	28
Symbicort	Budesonide/Formoterol Fumarate	65	14
Simvastatin	Simvastatin	64	21
Alprazolam	Alprazolam	63	18
Meloxicam	Meloxicam	62	20
Mounjaro	Tirzepatide	59	18
Naproxen	Naproxen	59	25
Allopurinol	Allopurinol	55	19
Pioglitazone Hcl	Pioglitazone Hcl	54	15
Clopidogrel	Clopidogrel Bisulfate	53	19
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	53	15
Ventolin Hfa	Albuterol Sulfate	53	16
Glipizide	Glipizide	52	16
Bupropion Xl	Bupropion Hcl	51	21
Prednisone	Prednisone	50	37
Ketoconazole	Ketoconazole	49	21
Carvedilol	Carvedilol	47	14
Sertraline Hcl	Sertraline Hcl	47	12
Trulicity	Dulaglutide	47	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	38
Baclofen	Baclofen	43	13
Spironolactone	Spironolactone	43	12
Eliquis	Apixaban	42	11
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Finasteride	Finasteride	40	15
Duloxetine Hcl	Duloxetine Hcl	39	14
Fluconazole	Fluconazole	38	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	11
Mupirocin	Mupirocin	36	25
Vitamin D2	Ergocalciferol (Vitamin D2)	36	14
Buspirone Hcl	Buspirone Hcl	35	suppressed
Jardiance	Empagliflozin	34	14
Constulose	Lactulose	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Gemfibrozil	Gemfibrozil	31	11
Ibuprofen	Ibuprofen	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Amoxicillin	Amoxicillin	29	23
Bupropion Hcl	Bupropion Hcl	29	11
Ondansetron Hcl	Ondansetron Hcl	29	18
Pravastatin Sodium	Pravastatin Sodium	29	11
Topiramate	Topiramate	29	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	13
Propranolol Hcl	Propranolol Hcl	26	suppressed
Clindamycin Hcl	Clindamycin Hcl	25	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	13
Hydrocortisone	Hydrocortisone	25	13
Mometasone Furoate	Mometasone Furoate	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	19
Farxiga	Dapagliflozin Propanediol	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	20	suppressed
Ezetimibe	Ezetimibe	20	11
Irbesartan	Irbesartan	20	suppressed
Pregabalin	Pregabalin	20	12
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Metronidazole	Metronidazole	19	17
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	13
Clonidine Hcl	Clonidine Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Digoxin	Digoxin	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	12
Atenolol	Atenolol	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Risperidone	Risperidone	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Linzess	Linaclotide	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Nystatin	Nystatin	15	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	14	suppressed
Diazepam	Diazepam	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Lactulose	Lactulose	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	11
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error